Otsuka Holdings Co., Ltd. (OTSKY)

Market Cap	24.62B
Revenue (ttm)	14.82B
Net Income (ttm)	2.18B
Shares Out	n/a
EPS (ttm)	4.03
PE Ratio	11.28
Forward PE	n/a
Dividend	0.81 (3.45%)
Ex-Dividend Date	Dec 31, 2024

Volume	200
Average Volume	69,051
Open	23.42
Previous Close	23.51
Day's Range	23.29 - 23.45
52-Week Range	19.30 - 32.41
Beta	0.10
RSI	37.38
Earnings Date	Apr 30, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKY

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.

Financial numbers in JPY